Company: CSTAF
Filing Date: 2025-04-02
Form Type: 10-K
Source: 0001213900-25-027555
Chunk: 90

Company: Constellation Acquisition Corp I
Filing Date: 2025-04-02
Form: 10-K
Item: Item 1
Chunk 90
---
 as a consequence of our “staggered” board of directors, only a minority of the board
of directors will be considered for election and our Sponsor, because of its ownership position, will control the outcome, as only holders
of our Class B ordinary shares will have the right to vote on the election of directors and to remove directors prior to our Business
Combination. Accordingly, our Sponsor will continue to exert control at least until the completion of our Business Combination. In addition,
we have agreed not to enter into a definitive agreement regarding a Business Combination without the prior consent of our Sponsor.

49

We may amend the terms of the warrants in a manner that
may be adverse to holders of public warrants with the approval by the holders of at least 50% of the then outstanding public warrants.
As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number of our Class
A ordinary shares purchasable upon exercise of a warrant could be decreased, all without your approval.

Our warrants were issued in registered form under a warrant agreement
between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the
warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision or correct any mistake,
including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant agreement
set forth in this Annual Report, but requires the approval by the holders of at least 50% of the then- outstanding public warrants to
make any change that adversely affects the interests of the registered holders of public warrants. Accordingly, we may amend the terms
of the public warrants in a manner adverse to a holder if holders of at least 50% of the then-outstanding public warrants approve of such
amendment and, solely with respect to any amendment to the terms of the private placement warrants or any provision of the warrant agreement
with respect to the private placement warrants, 50% of the number of the then outstanding private placement warrants. Although our ability
to amend the terms of the public warrants with the consent of at least 50% of the then-outstanding public warrants is unlimited, examples
of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into
cash, shorten the exercise period or decrease the number of Class A ordinary shares purchasable upon exercise of a warrant. We may redeem
your